Skip to main content
. 2022 Jan 26;14(2):290. doi: 10.3390/pharmaceutics14020290

Table 3.

Screening of cytotoxicity of tested compounds against MCF-7, HCT-116, and NHDF-Neo cells for 24, 48, and 72 h incubation time.

Compound Activity IC50 [µM] a
MCF-7
24 h 48 h 72 h
DOX 3.42 ± 0.03 0.58 ± 0.02 0.57 ± 0.02
DOX-micelles 1.96 ± 0.01 0.52 ± 0.02 0.13 ± 0.01
8HQ 7.17 ± 0.21 2.86 ± 0.09 3.01 ± 0.05
8HQ-mic b 4.82 ± 0.17 2.11 ± 0.11 0.75 ± 0.04
8HQ-Glu 65.86 ± 2.22 62.07 ± 1.84 63.57 ± 2.01
8HQ-Glu-mic c 37.57 ± 0.92 3.85 ± 0.19 0.59 ± 0.02
8HQ-Gal 26.39 ± 1.28 23.15 ± 0.99 24.60 ± 0.52
8HQ-Gal-mic d 5.59 ± 0.14 0.21 ± 0.01 0.19 ± 0.01
Compound Activity IC50 [µM] a
HCT-116
24 h 48 h 72 h
DOX 6.94 ± 0.33 0.095 ± 0.01 0.105 ± 0.01
DOX-micelles 2.36 ± 0.08 0.45 ± 0.01 0.078 ± 0.01
8HQ 9.33 ± 0.22 4.12 ± 0.12 4.40 ± 0.08
8HQ-mic b 4.95 ± 0.16 1.80 ± 0.05 0.91 ± 0.04
8HQ-Glu 49.67 ± 1.32 47.20 ± 1.14 45.73 ± 1.81
8HQ-Glu-mic c 49.60 ± 2.11 8.46 ± 0.12 0.38 ± 0.02
8HQ-Gal 22.10 ± 0.84 23.09 ± 0.92 22.52 ± 1.02
8HQ-Gal-mic d 10.83 ± 0.33 2.64 ± 0.12 0.017 ± 0.01
Compound Activity IC50 [µM] a
NHDF-Neo
24 h 48 h 72 h
DOX >20 >20 2.71 ± 0.08
DOX-micelles >20 3.93 ± 0.12 2.50 ± 0.06
8HQ 9.34 ± 0.25 8.97 ± 0.19 9.64 ± 0.32
8HQ-mic b 5.18 ± 0.26 3.96 ± 0.12 3.97 ± 0.09
8HQ-Glu 41.00 ± 2.01 41.11 ± 1.73 30.02 ± 0.94
8HQ-Glu-mic c 41.70 ± 1.42 22.53 ± 0.65 13.38 ± 0.39
8HQ-Gal 20.14 ± 0.75 21.77 ± 0.89 18.30 ± 0.74
8HQ-Gal-mic d 7.47 ± 0.17 5.55 ± 0.17 2.79 ± 0.13

a Cytotoxicity was evaluated using the MTT assay; b 8HQ-loaded micelles; c 8HQ-Glu-loaded micelles; d 8HQ-Gal-loaded micelles. Data are presented as the mean ± SD (n = 3).